Walleye Trading LLC Biocryst Pharmaceuticals Inc Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $228,108 - $310,099	45,805 Added 460.07%	55,761 $334,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $63,516 - $74,970	9,466 Added 1931.84%	9,956 $70,000
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $3,410 - $4,316	490 New	490 $3,000
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $483,168 - $653,427	46,016 Added 286.01%	62,105 $712,000
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $50,378 - $69,147	4,669 Added 40.88%	16,089 $203,000
Q2 2022 Aug 08, 2022	SELL	$7.89 - $17.88 $62,425 - $141,466	-7,912 Reduced 40.93%	11,420 $121,000
Q1 2022 May 16, 2022	SELL	$11.56 - $19.76 $201,028 - $343,626	-17,390 Reduced 47.36%	19,332 $314,000
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $983,627 - $1.36 Million	-87,981 Reduced 70.55%	36,722 $509,000
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $298,495 - $370,755	21,006 Added 20.26%	124,703 $1.79 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $985,121 - $1.79 Million	103,697 New	103,697 $1.64 Million
Q1 2021 May 17, 2021	SELL	$7.37 - $13.61 $138,349 - $255,486	-18,772 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.37 - $8.61 $63,261 - $161,626	18,772 New	18,772 $140,000
Q2 2020 Aug 14, 2020	SELL	$1.9 - $5.61 $79,963 - $236,102	-42,086 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.6 - $4.11 $4,800 - $12,330	-3,000 Reduced 6.65%	42,086 $84,000
Q4 2019 Feb 14, 2020	BUY	$1.59 - $3.45 $71,686 - $155,546	45,086 New	45,086 $156,000
Q4 2018 Feb 14, 2019	SELL	$6.51 - $9.6 $8,104 - $11,952	-1,245 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.52 - $7.99 $6,872 - $9,947	1,245 New	1,245 $9,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

Vanguard Group Inc Valley Forge, PA

20.3M
Shares

$154 Million
0.0% of portfolio
Black Rock Inc. New York, NY

20M
Shares

$151 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

11.9M
Shares

$89.8 Million
1.36% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.09M
Shares

$68.8 Million
5.66% of portfolio
State Street Corp Boston, MA

8.85M
Shares

$67 Million
0.0% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account